JPMORGAN CHASE & CO - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 50 filers reported holding REGULUS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$0
-100.0%
7890.0%0.00%
Q2 2018$1,000
-90.0%
789
-89.6%
0.00%
Q3 2017$10,000
-41.2%
7,606
-54.7%
0.00%
Q2 2017$17,00016,7870.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
RA Capital Management 4,039,823$26,420,0003.79%
Foresite Capital Management II, LLC 1,750,269$11,447,0003.48%
ARGONAUT CAPITAL MANAGEMENT CORP 75,000$491,0001.65%
Abingworth LLP 327,350$2,138,0001.25%
Trellus Management Company, LLC 100,000$654,0000.96%
Cormorant Asset Management, LP 896,522$5,863,0000.94%
DAFNA Capital Management LLC 90,000$589,0000.58%
ORACLE INVESTMENT MANAGEMENT INC 749,064$4,898,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
View complete list of REGULUS THERAPEUTICS INC shareholders